176 related articles for article (PubMed ID: 15604208)
1. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta.
Luo X; Ding L; Xu J; Chegini N
Endocrinology; 2005 Mar; 146(3):1097-118. PubMed ID: 15604209
[TBL] [Abstract][Full Text] [Related]
3. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
4. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
5. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
6. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
7. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.
Pan Q; Luo X; Chegini N
Mol Hum Reprod; 2010 Mar; 16(3):215-27. PubMed ID: 19906824
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
10. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Luo X; Ding L; Ripley D
Mol Cell Endocrinol; 2003 Nov; 209(1-2):9-16. PubMed ID: 14604812
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
Chegini N; Tang XM; Ma C
J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
Pan Q; Luo X; Chegini N
J Cell Mol Med; 2008; 12(1):227-40. PubMed ID: 18182067
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A serves as a primary pathway in activation of Nur77 expression by gonadotropin-releasing hormone in the LbetaT2 mouse pituitary gonadotroph tumor cell line.
Hamid T; Malik MT; Millar RP; Kakar SS
Int J Oncol; 2008 Nov; 33(5):1055-64. PubMed ID: 18949369
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
Wang Y; Matsuo H; Kurachi O; Maruo T
Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
[TBL] [Abstract][Full Text] [Related]
18. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
Tien ES; Davis JW; Vanden Heuvel JP
J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma.
Chegini N; Kornberg L
J Soc Gynecol Investig; 2003 Jan; 10(1):21-6. PubMed ID: 12517589
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
